Learn more about how CB-CAPS and AVISE testing can help your busy practice with the differential diagnosis, prognosis, monitoring, and therapeutic optimization of lupus and related …

AVISE testing provides state-of-the-art insight to aid physicians in the diagnosis, prognosis and monitoring of autoimmune conditions.

Delays in diagnosis can lead to increased morbidity, higher mortality rates, and escalating healthcare costs. AVISE CTD addresses the challenge of overlapping symptoms by providing …

AVISE CTD combines AVISE Lupus, a 10-marker diagnostic test designed to help rule-in or rule-out lupus, with an expanded connective tissue disease panel to aid in the differential diagnosis …

In the AVISE Lupus algorithm, patients are first screened using an anti-dsDNA ELISA assay. Those who test positive are then confirmed with the Crithidia luciliae IFA

Menu. Our Tests. AVISE CTD – Advanced Lupus & Autoimmune Rheumatic Disease Test; AVISE SLE Monitor – Lupus Disease Monitoring Test; AVISE HCQ & AVISE MTX – Medication …

AVISE testing uses advanced technologies and patented biomarkers to improve sensitivity of testing. AVISE offers several tests to identify autoimmune diseases, such as: Antiphospholipid …

The following AVISE tests (AVISE CarP, AVISE CB-CAPs, AVISE CTD, AVISE Lupus, AVISE HCQ, AVISE MTX, AVISE SLE Monitor, AVISE SLE Prognostic) were developed, and …

The AVISE ® SLE Monitor test goes beyond standard lupus testing by incorporating six specialized biomarkers that reveal a more accurate and complete picture of your disease …

Easily find the AVISE testing location closest to you. If you need assistance an AVISE Provider Relations team member can help.